Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris
Clinical trial NCT03322137 · COMPLETED
Trial details
- NCT number
- NCT03322137
- Sponsor
- Sienna Biopharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-10
- Primary completion
- 2018-09-10
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.